View in EDS

ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.

Saved in:
Bibliographic Details
Title: ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
Authors: Piotrowska Z; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts., Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Voon PJ; Radiotherapy and Oncology Department, Hospital Umum Sarawak, Kuching, Malaysia., Pang YK; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia., How SH; Department of Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Malaysia., Kim SW; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Cortinovis D; Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University Milano-Bicocca, Milan, Italy., de Castro Carpeño J; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC, IdiPAZ, Madrid, Spain., Tiseo M; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Rodríguez Abreu D; Department of Medical Oncology, Gran Canaria University Hospital, Las Palmas de Gran Canaria, Spain., Ramalingam SS; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia., Li J; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland., Servidio L; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland., Taylor R; Oncology Biometrics, AstraZeneca (United Kingdom), Macclesfield, United Kingdom., Hartmaier R; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Markovets AA; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Tang KH; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Source: Cancer discovery [Cancer Discov] 2026 Jun 01; Vol. 16 (6), pp. 1074-1086.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41790042
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Piotrowska+Z%22">Piotrowska Z</searchLink>; Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Ahn+MJ%22">Ahn MJ</searchLink>; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Voon+PJ%22">Voon PJ</searchLink>; Radiotherapy and Oncology Department, Hospital Umum Sarawak, Kuching, Malaysia.<br /><searchLink fieldCode="AU" term="%22Pang+YK%22">Pang YK</searchLink>; Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.<br /><searchLink fieldCode="AU" term="%22How+SH%22">How SH</searchLink>; Department of Medicine, Kulliyyah of Medicine, International Islamic University Malaysia, Kuantan, Malaysia.<br /><searchLink fieldCode="AU" term="%22Kim+SW%22">Kim SW</searchLink>; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Cortinovis+D%22">Cortinovis D</searchLink>; Oncology Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; Department of Medicine, University Milano-Bicocca, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22de+Castro+Carpeño+J%22">de Castro Carpeño J</searchLink>; Department of Medical Oncology, Hospital Universitario La Paz, CIBERONC, IdiPAZ, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Tiseo+M%22">Tiseo M</searchLink>; Department of Medicine and Surgery, University of Parma, Parma, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Rodríguez+Abreu+D%22">Rodríguez Abreu D</searchLink>; Department of Medical Oncology, Gran Canaria University Hospital, Las Palmas de Gran Canaria, Spain.<br /><searchLink fieldCode="AU" term="%22Ramalingam+SS%22">Ramalingam SS</searchLink>; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Servidio+L%22">Servidio L</searchLink>; Global Medical Affairs, Oncology Business Unit, AstraZeneca (United States), Gaithersburg, Maryland.<br /><searchLink fieldCode="AU" term="%22Taylor+R%22">Taylor R</searchLink>; Oncology Biometrics, AstraZeneca (United Kingdom), Macclesfield, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hartmaier+R%22">Hartmaier R</searchLink>; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Markovets+AA%22">Markovets AA</searchLink>; Oncology Data Science, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Tang+KH%22">Tang KH</searchLink>; Translational Medicine, Research and Early Development, Oncology R&D, AstraZeneca (United States), Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Cho+BC%22">Cho BC</searchLink>; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101561693%22">Cancer discovery</searchLink> [Cancer Discov] 2026 Jun 01; Vol. 16 (6), pp. 1074-1086.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Association+for+Cancer+Research%22">American Association for Cancer Research </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101561693 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2159-8290 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2221598274%22">21598274 </searchLink><i>NLM ISO Abbreviation: </i>Cancer Discov <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41790042
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1158/2159-8290.CD-25-0960
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1074
    Titles:
      – TitleFull: ELIOS: A Multicenter, Molecular Profiling Study of Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer Treated with First-Line Osimertinib.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Piotrowska Z
      – PersonEntity:
          Name:
            NameFull: Ahn MJ
      – PersonEntity:
          Name:
            NameFull: Voon PJ
      – PersonEntity:
          Name:
            NameFull: Pang YK
      – PersonEntity:
          Name:
            NameFull: How SH
      – PersonEntity:
          Name:
            NameFull: Kim SW
      – PersonEntity:
          Name:
            NameFull: Cortinovis D
      – PersonEntity:
          Name:
            NameFull: de Castro Carpeño J
      – PersonEntity:
          Name:
            NameFull: Tiseo M
      – PersonEntity:
          Name:
            NameFull: Rodríguez Abreu D
      – PersonEntity:
          Name:
            NameFull: Ramalingam SS
      – PersonEntity:
          Name:
            NameFull: Li J
      – PersonEntity:
          Name:
            NameFull: Servidio L
      – PersonEntity:
          Name:
            NameFull: Taylor R
      – PersonEntity:
          Name:
            NameFull: Hartmaier R
      – PersonEntity:
          Name:
            NameFull: Markovets AA
      – PersonEntity:
          Name:
            NameFull: Tang KH
      – PersonEntity:
          Name:
            NameFull: Cho BC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 06
              Text: 2026 Jun 01
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2159-8290
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 6
          Titles:
            – TitleFull: Cancer discovery
              Type: main
ResultId 1